Skip to main content
. 2021 Feb 2;13(3):572. doi: 10.3390/cancers13030572

Figure 2.

Figure 2

Presence of SCAs, ATRX deletion, and TERT gain within groups by age and stage. Presence of segmental chromosomal alterations (SCAs) that were associated with a significantly lower event-free (EFS) and overall survival (OS) in a univariate analysis within groups differentiated by age (≤/>12 months) and stage by International Neuroblastoma Staging System (INSS) (localized/4S or stage 4).